ribosom
synthes
cyclic
peptid
discov
bacteria
fungi
plant
anim
wide
rang
size
structur
biolog
properti
figur
pharmaceut
industri
gain
interest
peptid
drug
cyclic
peptid
shown
great
potenti
stabil
degrad
theta
defensin
qdefensin
known
class
cyclic
peptid
mammal
focu
review
need
understood
broader
context
cyclic
peptid
share
common
featur
challeng
describ
challeng
address
class
cyclic
peptid
might
add
understand
qdefensin
cyclic
peptid
describ
herein
direct
gene
product
note
mani
cyclic
peptid
synthes
nonribosom
exampl
cyclosporin
fungal
peptid
use
immun
suppress
also
grow
number
bioactiv
peptid
artifici
cycliz
take
advantag
increas
stabil
afford
cyclic
peptid
backbon
exampl
cycliz
cone
snail
venom
peptid
show
increas
stabil
potenc
anim
pain
model
cyclic
peptid
discoveri
challeng
lack
termini
make
cyclic
peptid
resist
tradit
sequenc
method
furthermor
unknown
posit
termini
small
size
gene
hamper
search
cyclic
peptid
nucleic
acid
level
howev
new
search
method
develop
particularli
use
mass
spectrometri
data
cyclic
peptid
discov
collect
cybas
anticip
new
discoveri
method
develop
class
cyclic
peptid
emerg
novel
bioactiv
applic
cyclic
peptid
found
divers
rang
organ
character
stabil
role
defens
one
class
cyclic
peptid
found
mammal
possibl
look
hard
enough
technolog
need
identifi
fulli
develop
also
yet
understand
intrigu
biosynthesi
two
separ
gene
product
address
challeng
requir
applic
chemic
tool
insight
class
cyclic
peptid
herein
highlight
recent
develop
character
theta
defensin
describ
import
role
chemistri
play
delin
mode
action
furthermor
emphas
potenti
theta
defensin
antimicrobi
agent
scaffold
peptid
drug
design
figur
divers
cyclic
peptid
cyclic
peptid
occur
bacteria
plant
anim
fungi
b
vari
sequenc
size
disulfid
connect
amino
acid
sequenc
kalata
aamanitin
disulfid
bond
grey
line
posttransl
modifi
residu
mark
asterisk
c
threedimension
structur
pdb
kalata
pdb
pdb
aamanitin
pdb
shown
cartoon
geneencod
cyclic
peptid
produc
bacteria
typic
compris
amino
acid
first
report
class
ribosom
cyclic
peptid
cyclic
backbon
bacteriocin
elucid
cyclic
bacteriocin
produc
bacteria
phylum
firmicut
globular
structur
compris
ahelic
cyanobacteria
produc
cyanobactin
contain
posttransl
modif
addit
cycliz
cyclic
bacteriocin
cyanobactin
seem
produc
defens
compet
bacteria
potenti
applic
antimicrobi
agent
contrast
cyclic
pilin
structur
role
use
transfer
genet
materi
biosynthet
mechan
bacteri
cyclic
peptid
better
understood
eukaryot
counterpart
gene
encod
often
cluster
gene
encod
process
enzym
understand
mechan
bacteria
enabl
recombin
cyclic
peptid
product
thu
facilit
develop
cyclic
peptid
therapeut
fungi
amanitacea
famili
produc
two
class
cyclic
peptid
amatoxin
phallocidin
contain
unusu
posttransl
modif
phallocidin
compris
seven
residu
cystrp
sulfid
link
amatoxin
compris
eight
residu
cystrp
sulfoxid
link
hydroxyl
fungal
cyclic
peptid
flank
pro
residu
nand
ctermin
process
site
thought
cycliz
prolyl
oligopeptidas
amatoxin
phallocidin
highli
toxic
human
amatoxin
inhibit
transcript
bind
rna
polymeras
ii
phallocidin
bind
factin
stabil
filament
structur
within
cell
plant
cyclic
peptid
group
three
famili
cyclotid
sunflow
trypsin
inhibitor
orbitid
cyclotid
compris
approxim
residu
character
cyclic
cystin
knot
motif
follow
discoveri
prototyp
cyclotid
kalata
cyclotid
found
violacea
rubiacea
fabacea
solanacea
cucurbitacea
famili
structur
activ
applic
extens
review
cyclotid
divid
bracelet
trypsin
inhibitor
subfamili
base
sequenc
activ
although
natur
function
cyclotid
thought
plant
defens
molecul
insect
pest
sever
unrel
pharmacolog
activ
report
antihiv
antibacteri
antitumor
hemolyt
uteroton
activ
membran
bind
appear
mechan
common
activ
exact
mechan
cyclotid
biosynthesi
still
clear
howev
thought
cyclotid
precursor
cleav
n
terminu
asparaginyl
endopeptidas
aep
carri
transpeptid
reaction
form
cyclic
backbon
addit
obviou
applic
agricultur
plant
protect
cyclotid
shown
potenti
stabl
scaffold
design
peptid
drug
possibl
develop
includ
product
plant
factori
sunflow
trypsin
inhibitor
smaller
cyclotid
compris
residu
one
disulfid
bond
nucleic
acid
sequenc
encod
sunflow
famili
cyclic
peptid
buri
within
gene
encod
albumin
seed
storag
protein
cycliz
aep
potent
trypsin
inhibitori
activ
sunflow
trypsin
inhibitor
exploit
design
potenti
anticanc
compound
chemic
synthes
analogu
inhibit
matriptas
kallikreinrel
proteas
involv
breast
prostat
cancer
respect
recent
report
recommend
name
orbitid
small
cyclic
plant
peptid
earlier
known
cyclolinopeptid
caryophyllaceaetyp
peptid
orbitid
compris
five
amino
acid
contrast
cyclotid
high
proport
hydrophob
residu
lack
disulfid
bond
orbitid
discov
ten
plant
famili
cyclotid
natur
function
plant
thought
antiherbivor
antibacteri
agent
although
mani
differ
bioactiv
vivo
dna
precursor
orbitid
identifi
saponaria
vaccaria
biosynthesi
appear
involv
cleavag
precursor
oligopeptidas
follow
cycliz
mediat
serin
proteas
angewandt
review
j
craik
c
conibear
sinc
discoveri
signific
progress
made
understand
antimicrobi
activ
qdefensin
mani
question
remain
especi
regard
biosynthesi
recent
progress
synthesi
character
qdefensin
facilit
effort
address
unsolv
problem
identifi
new
applic
qdefensin
focu
challeng
opportun
remaind
articl
defensin
disulfiderich
peptid
form
part
mammalian
innat
immun
system
provid
defens
microbi
pathogen
regul
immun
respons
adefensin
compris
amino
acid
contain
three
disulfid
bond
ivi
iiiv
iiiv
arrang
figur
six
adefensin
found
human
human
neutrophil
peptid
human
defensin
express
paneth
cell
intestin
bdefensin
larger
adefensin
compris
approxim
amino
acid
three
disulfid
bond
iv
iiiv
iiivi
arrang
bdefensin
found
human
predominantli
epitheli
cell
male
reproduct
tract
third
class
mammalian
defensin
qdefensin
name
structur
similar
greek
letter
theta
compris
residu
three
disulfid
bond
ivi
iiv
iiiiv
arrang
first
cyclic
mammalian
peptid
rhesu
qdefensin
discov
studi
defensin
express
rhesu
macaqu
macacca
mulata
leukocyt
fraction
screen
leukocyt
extract
result
isol
peptid
potent
antibacteri
activ
sequenc
overlap
fragment
led
elucid
cyclic
backbon
seri
thermolysin
digest
reveal
three
parallel
disulfid
bond
term
cyclic
cystin
ladder
search
gene
encod
surprisingli
reveal
two
gene
genbank
encod
nineresidu
fragment
demidefensin
follow
three
residu
stop
codon
figur
qdefensin
gene
pseudogen
name
deft
defensin
theta
ydeft
gene
respect
gene
appear
truncat
adefensin
gene
two
encod
demidefensin
splice
togeth
form
cyclic
qdefensin
date
qdefensin
cyclic
peptid
biosynthes
two
separ
gene
product
unsolv
question
heterodimer
qdefensin
abund
homodimer
qdefensin
isol
figur
mammalian
defensin
mammalian
defensin
divid
three
class
adefensin
eg
bdefensin
eg
qdefensin
eg
amino
acid
repres
onelett
code
grey
line
repres
disulfid
bond
disulfid
connect
shown
roman
numer
b
threedimension
structur
pdb
pdb
pdb
shown
cartoon
represent
disulfid
bond
grey
figur
qdefensin
synthes
binari
ligat
two
nineresidu
demidefensin
demidefensin
gene
compris
three
exon
two
intron
b
demidefensin
precursor
compris
signal
sequenc
proseg
nineresidu
demidefensin
light
grey
dark
grey
threeresidu
tail
amino
acid
repres
onelett
code
asterisk
repres
stop
codon
c
propos
biosynthet
mechan
one
intermolecular
two
intramolecular
disulfid
bond
grey
line
join
two
demidefensin
ntermin
proseg
cleav
two
new
peptid
bond
ligat
demidefensin
concomit
loss
tail
residu
form
cyclic
peptid
chemi
homodim
illustr
n
demidefensin
gene
give
rise
n
qdefensin
third
demidefensin
later
identifi
six
correspond
qdefensin
isol
macaqu
neutrophil
although
amount
qdefensin
peptid
vari
much
factor
three
individu
account
around
total
qdefensin
content
prefer
heterodimer
speci
homodimer
speci
high
proport
compar
five
variant
might
result
differ
gene
copi
number
differ
express
level
question
remain
address
anoth
major
challeng
understand
qdefensin
gene
human
exist
pseudogen
give
rise
qdefensin
peptid
selst
cowork
note
sequenc
similar
gene
encod
gene
encod
human
adefensinrel
pseudogen
genbank
contain
stop
codon
signal
sequenc
lehrer
cowork
synthes
qdefensin
would
produc
two
transcript
pseudogen
absenc
prematur
stop
codon
peptid
name
retrocyclin
show
potent
antihiv
activ
low
cytotox
ad
iron
twist
question
human
inherit
intact
qdefensin
gene
distribut
divers
less
known
distribut
divers
qdefensin
cyclic
peptid
time
write
review
cyclotid
isol
speci
plant
sinc
elucid
cyclic
structur
differ
qdefensin
isol
three
speci
primat
sinc
discoveri
contrast
might
reflect
rel
difficulti
obtain
primat
tissu
sampl
compar
plant
lack
effici
discoveri
tool
addit
six
qdefensin
isol
rhesu
macaqu
macacca
mulata
four
qdefensin
cdna
identifi
oliv
baboon
papio
anubi
leukocyt
suggest
ten
qdefensin
could
synthes
howev
five
isol
two
peptid
isol
hamadrya
baboon
papio
hamadrya
leukocyt
sequenc
maldim
ident
sequenc
respect
date
qdefensin
isol
peptid
level
name
accord
first
letter
speci
primat
found
howev
qdefensin
discov
new
speci
systemat
nomenclatur
need
develop
avoid
ambigu
miss
piec
understand
biosynthesi
qdefensin
lack
knowledg
sequenc
divers
sequenc
known
demidefensin
encod
gene
pseudogen
shown
tabl
qdefensin
isol
peptid
level
contain
six
cystein
residu
howev
interest
pan
troglodyt
pan
paniscu
pseudogen
encod
four
cystein
greatest
sequenc
variat
occur
four
residu
bturn
number
arginin
residu
result
charg
contrast
cyclotid
acycl
qdefensin
analogu
report
observ
might
reflect
differ
biosynthet
mechan
cyclotid
distribut
qdefensin
primat
speci
origin
stop
codon
ydeft
gene
yet
understood
phylogenet
studi
speci
old
new
world
primat
identifi
new
deft
ydeft
gene
tabl
conclud
silenc
mutat
tabl
sequenc
demidefensin
encod
qdefensin
deft
gene
pseudogen
ydeft
demidefensin
sequenc
macaca
mulata
homo
sapien
human
rcicgrgicrl
rcicgrricrl
pongo
pygmaeu
abelii
gorilla
gorilla
lowland
gorilla
rcicgrgicrl
pan
troglodyt
common
chimpanze
rciggrgicgl
pan
paniscu
bonobo
chimpanze
rciggrgicgl
hylob
syndactylu
siamang
rcicgrgvcrll
macaca
nemestrina
pigtail
macaqu
rcicrrgvcqll
colobu
guereza
kikutensi
kikuyu
colobu
papio
anubi
oliv
baboon
papio
hamadrya
hamadrya
baboon
demidefensin
sequenc
cystein
bold
threeresidu
tail
grey
angewandt
review
j
craik
c
conibear
ydeft
gene
occur
common
ancestor
human
chimpanze
gorilla
around
million
year
ago
orangutan
lineag
diverg
orangutan
pongo
pygmaeu
abelii
intact
silenc
copi
deft
gene
furthermor
stop
codon
appear
arisen
seri
stepwis
mutat
codon
cact
histidin
old
world
monkey
cag
glutamin
orangutan
tag
stop
new
world
monkey
accord
role
innat
immun
qdefensin
produc
mainli
bone
marrow
express
phagocyt
cell
neutrophil
monocyt
lymphocyt
eosinophil
appear
secret
local
azurophil
granul
howev
express
paneth
cell
crypt
small
intestin
rhesu
macaqu
report
recent
human
express
ydeft
gene
highest
bone
marrow
also
observ
skelet
muscl
spleen
thymu
testi
inabl
inat
produc
qdefensin
make
human
suscept
hiv
burn
question
difficult
answer
conclus
qdefensin
peptid
found
human
six
ydeft
gene
human
genom
five
chromosom
gi
upstream
gene
one
chromosom
although
inhibit
two
thai
subtyp
sequenc
deft
gene
persist
seroneg
femal
sexwork
thailand
show
ydeft
gene
result
led
conclus
resist
women
due
qdefensin
product
nevertheless
possibl
remain
isol
popul
might
retain
intact
deft
gene
henc
intrins
protect
hiv
gene
structur
biosynthesi
deft
gene
compris
three
exon
two
intron
figur
exon
encod
propeptid
compris
signal
peptid
proseg
nineresidu
demidefensin
threeresidu
tail
figur
b
although
structur
disulfid
connect
aand
qdefensin
differ
common
featur
precursor
peptid
suggest
similar
process
mechan
might
use
understand
biosynthet
mechan
challeng
class
cyclic
peptid
much
less
known
biosynthesi
qdefensin
class
cycliz
thought
arisen
separ
differ
kingdom
although
similar
featur
proteasemedi
transpeptid
present
cyclotid
conserv
glyleupro
sequenc
n
termini
cyclotid
propeptid
recogn
aep
proteas
ctermin
propeptid
thought
cleav
allow
n
terminu
cyclotid
replac
recognit
site
ntermin
gli
act
nucleophil
cycliz
peptid
chain
similarli
trbc
pilin
bacteria
cleav
cycliz
traf
proteas
qdefensin
biosynthesi
also
probabl
involv
proteas
howev
two
new
peptid
bond
need
form
two
peptid
three
disulfid
bond
form
two
demidefensin
build
qdefensin
like
explan
two
disulfidestabil
bhairpin
form
held
togeth
interchain
disulfid
ligat
figur
c
structur
properti
precursor
might
also
direct
associ
demidefensin
ligat
possibl
develop
aris
elucid
qdefensin
biosynthesi
identif
new
cyclic
peptid
insight
peptid
cycliz
arisen
mammal
evid
whether
human
cell
retain
abil
process
demidefensin
transcript
inconclus
two
separ
studi
human
promyelocyt
cell
abl
process
adefensin
transfect
proqdefensin
cdna
one
studi
neither
matur
qdefensin
qdefensin
precursor
detect
studi
presenc
cyclic
retrocyclin
antihiv
activ
report
furthermor
latter
studi
aminoglycosid
use
read
stop
codon
human
ydeft
gene
restor
endogen
express
retrocyclin
yeast
twohybrid
screen
use
identifi
protein
interact
defensin
precursor
might
involv
process
stromal
cell
deriv
protein
part
endoplasm
reticulum
chaperon
complex
interact
b
qdefensin
thu
suggest
might
role
biosynthesi
packag
structur
stabil
structur
natur
occur
modifi
qdefensin
determin
nmr
data
give
insight
stabil
mechan
action
bsheet
structur
crossbrac
three
disulfid
bond
predict
molecular
dynam
model
later
confirm
nmr
structur
pdb
solut
broaden
nmr
signal
nuclear
overhaus
enhanc
noe
interact
indic
flexibl
figur
structur
synthet
retrocyclin
pdb
determin
presenc
sodium
dodecyl
sulphat
sd
micel
might
stabi
chemi
lize
extend
conform
peptid
recent
develop
nmr
method
facilit
determin
welldefin
structur
three
qdefensin
character
cyclic
cystin
ladder
figur
b
pdb
pdb
first
symmetr
qdefensin
pdb
structur
compris
two
highli
constrain
bstrand
join
turn
heteronuclear
noe
predict
order
paramet
suggest
qdefensin
rigid
previous
thought
sever
structur
qdefensin
avail
protein
data
bank
model
peptid
design
applic
possibl
role
selfassoci
mechan
action
qdefensin
still
unclear
densiti
ultracentrifug
nmr
diffus
measur
suggest
retrocyclin
form
trimer
high
concentr
model
propos
peptid
selfassoci
along
longitudin
axe
disulfid
bond
face
inward
base
select
broaden
cystein
signal
nmr
diffus
measur
support
hypothesi
extend
concentr
rang
suggest
aggreg
state
might
form
disulfid
connect
cyclic
cystin
ladder
well
establish
confirm
sever
method
comput
method
predict
disulfid
bond
connect
peptid
comparison
energyminim
structur
possibl
disulfid
connect
calcul
probabl
possibl
disulfid
connect
use
padloc
pattern
disulfid
local
constraint
measur
cysteinecystein
distanc
structur
calcul
without
disulfid
bond
restraint
constrain
structur
qdefensin
give
remark
stabil
consist
resist
high
concentr
proteas
inflam
tissu
synthet
qdefensin
analogu
vari
number
arrang
disulfid
bond
reveal
depend
structur
stabil
cyclic
cystin
ladder
although
analogu
three
two
one
central
disulfid
bond
structur
stabl
lack
disulfid
bond
cyclic
backbon
unstructur
rapidli
degrad
serum
nmr
studi
show
qdefensin
analogu
two
three
disulfid
bond
retain
structur
temperatur
contrast
disulfid
bond
necessari
antibacteri
membranebind
properti
howev
cyclic
cystin
ladder
might
role
molecular
recognit
antibacteri
activ
physiolog
salt
concentr
acycl
qdefensin
analogu
weaker
antibacteri
activ
cyclic
qdefensin
suggest
cyclic
backbon
import
activ
dretrocyclin
analogu
synthes
even
greater
stabil
show
potent
antihiv
activ
lretrocyclin
synthesi
access
qdefensin
chemic
synthesi
figur
facilit
studi
activ
mechan
earli
synthes
employ
fluorenylmethoxycarbonyl
fmoc
chemistri
assembl
peptid
backbon
solidphas
peptid
synthesi
spp
follow
oxid
bring
termini
residu
proxim
ligat
use
carbodiimid
edc
hydroxybenzotriazol
hobt
coupl
reagent
although
strategi
success
racem
cystein
residu
led
poor
yield
later
studi
three
method
investig
cycliz
oxid
precursor
obenzotriazolen
n
n
ntetramethyluroniumhexafluorophosph
hbtu
n
ndiisopropylethylamin
dipea
dimethylformamid
dmf
tri
dimethyl
amino
phosphonium
hexafluorophosph
bop
dipea
dmf
hobt
edc
dimethylsulfoxid
dmso
mixtur
product
obtain
hbtu
owe
side
reaction
bop
edchobt
gave
desir
major
product
edc
hobt
method
recommend
eas
purif
challeng
qdefensin
cycliz
larg
overcom
use
nativ
chemic
ligat
disulfid
bond
grey
first
qdefensin
structur
publish
suggest
flexibl
turn
region
b
symmetr
qdefensin
pdb
cyclic
cystin
ladder
motif
shown
stick
angewandt
review
j
craik
c
conibear
nativ
chemic
ligat
origin
develop
ligat
two
peptid
chain
also
ideal
synthesi
cyclic
peptid
especi
contain
multipl
cystein
residu
reaction
involv
thioester
exchang
ctermin
thioester
linker
free
thiol
ntermin
cystein
residu
format
peptid
bond
achiev
irrevers
n
acyl
transfer
regener
free
cystein
thiol
figur
inset
sever
nativ
qdefensin
analogu
synthes
use
boc
spp
follow
concurr
cycliz
nativ
chemic
ligat
oxid
fmoccompat
strategi
also
becom
avail
recent
onepot
cycliz
oxid
linear
qdefensin
precursor
report
lack
effici
vivo
cycliz
method
hinder
recombin
product
qdefensin
sever
semirecombin
approach
report
analogu
contain
three
nmethyl
residu
synthes
use
codon
reprogram
cellfre
express
system
peptid
precursor
contain
ctermin
cysproglycol
acid
sequenc
selfrearrang
form
diketopiperadin
thioester
rearrang
cycliz
peptid
advantag
approach
nonstandard
nmethyl
amino
acid
includ
bacteri
express
system
also
use
produc
rtdintein
precursor
cycliz
either
vitro
vivo
modifi
inteinspl
mechan
strategi
open
possibl
produc
cyclic
peptid
librari
isotopelabel
peptid
recombinantli
howev
yield
need
improv
largescal
product
chemic
modifi
qdefensin
mani
qdefensin
analogu
synthes
chemic
studi
mechan
action
optim
antibacteri
antivir
properti
exampl
includ
pseudogen
product
ly
mutant
enabl
label
chromophor
tyr
mutant
retroand
enantioanalogu
antihiv
carbohydratebind
studi
chemic
synthesi
also
use
produc
simplifi
retrocyclin
analogu
disulfidebond
analogu
qdefensin
analogu
contain
nonn
bioactiv
epitop
oxid
unprotect
cystein
residu
appear
give
nativ
ivi
iiv
iiiiv
ladder
disulfid
connect
nevertheless
one
studi
synthes
use
orthogon
protect
cystein
note
correct
disulfid
pair
assist
format
b
sheet
also
use
illustr
method
synthes
peptid
multipl
disulfid
complex
arrang
without
need
orthogon
protect
disulfid
bond
replac
watsoncrick
base
pair
result
analogu
similar
twist
bsheet
structur
nativ
low
hemolyt
activ
slightli
higher
antibacteri
activ
nativ
antimicrobi
activ
qdefensin
led
initi
discoveri
thought
natur
function
b
qdefensin
antimicrobi
mm
qdefensin
advantag
lower
sensit
physiolog
salt
concentr
cyclic
backbon
might
role
salt
insensit
acycl
analogu
three
time
less
activ
cyclic
e
coli
aureu
contrast
disulfid
bond
essenti
antibacteri
activ
qdefensin
also
bind
neutral
bacteri
toxin
analogu
activ
anthrax
bacilli
spore
bind
anthrax
lethal
toxin
howev
acycl
reduc
alkyl
analogu
retrocyclin
lack
activ
suggest
cyclic
backbon
disulfid
bond
role
toxin
bind
furthermor
activ
l
monocytogen
inhibit
listeriolysin
poreform
toxin
enabl
bacteria
escap
phagosom
figur
chemic
synthesi
qdefensin
involv
three
stage
assembl
peptid
chain
resin
cleavag
resin
cycliz
oxid
form
circular
backbon
three
disulfid
bond
grey
sphere
repres
resin
bead
amino
acid
repres
onelett
code
peptid
chain
assembl
c
n
terminu
coupl
ntermin
protect
grey
triangl
amino
acid
free
n
terminu
peptid
chain
inset
cycliz
nativ
chemic
ligat
reaction
involv
thioester
exchang
thioester
linker
cosr
c
terminu
peptid
free
thiol
ntermin
cystein
spontan
n
acyl
transfer
releas
free
cystein
thiol
form
peptid
bond
antifung
activ
c
albican
c
neoforman
v
dahlia
f
oxysporum
also
report
understand
mechan
antimicrobi
activ
complex
inflammatori
environ
numer
inhibitor
enhanc
present
extrem
challeng
antibacteri
activ
qdefensin
thought
caus
interact
membran
glycoprotein
enantiom
similar
antibacteri
activ
illustr
activ
clinic
isol
antibioticresist
aureu
p
aeruginosa
qdefensin
might
effect
resist
bacteria
target
cell
membran
rather
specif
enzym
differenti
scan
calorimetri
xray
scatter
measur
show
qdefensin
select
anion
membran
zwitterion
membran
indic
posit
charg
face
qdefensin
interact
anion
phospholipid
headgroup
surfac
plasmon
reson
spr
measur
also
show
higher
affin
anion
membran
zwitterion
membran
number
disulfid
bond
affect
membranebind
affin
measur
membran
curvatur
smallangl
xray
scatter
show
qdefensin
gener
neg
saddlesplay
curvatur
bacteri
membran
model
indic
potenti
membran
disrupt
depend
composit
cation
amino
acid
orient
circular
dichroism
xray
diffract
lipid
bilay
show
parallel
membranebound
state
transmembran
poreform
state
peptid
howev
transit
two
state
exact
mechan
unclear
solidst
nmr
measur
indic
nlabel
adopt
transmembran
orient
dilauroylphosphatidylcholin
dlpc
bilay
inplan
orient
thicker
popc
bilay
potent
antihiv
properti
retrocyclin
first
report
cole
cowork
therapeut
potenti
gener
much
interest
retrocyclin
inhibit
replic
low
micromolar
concentr
ad
cell
infect
directli
inactiv
viru
prevent
entri
block
fusion
viral
envelop
cell
membran
figur
inhibit
viral
entri
might
mediat
abil
retrocyclin
recogn
bind
sugar
molecul
cell
surfac
fluoresc
label
retrocyclin
analogu
form
patch
surfac
cell
cellfus
assay
spr
show
bind
cheptad
repeat
prevent
format
sixhelix
bundl
figur
dock
studi
reveal
glutam
acid
residu
cheptad
segment
arginin
residu
retrocyclin
might
bind
howev
mutat
residu
lead
resist
retrocyclin
mutat
render
viru
less
infect
recent
studi
effect
hiv
strain
resist
fusion
inhibitor
enfuvirtid
suggest
two
antivir
bind
differ
site
heptad
domain
furthermor
effect
compensatori
mutat
viral
strain
resist
studi
help
guid
develop
fusion
inhibitor
base
retrocyclin
import
role
chemistri
elucid
structureact
relationship
qdefenin
illustr
varieti
qdefensin
analogu
synthes
exampl
activ
retrocyclin
analogu
develop
replac
ly
anoth
studi
retroanalogu
retrocyclin
actual
found
increas
hiv
infect
abil
retrocyclin
inhibit
hiv
entri
depend
hiv
subtyp
possibl
differ
glycoprotein
display
hivinfect
human
cell
grown
presenc
select
resist
show
fivefold
decreas
suscept
three
mutat
identifi
resist
virus
envelop
glycoprotein
replac
neg
neutral
residu
posit
charg
residu
qdefensin
also
antiinfluenza
antiherp
activ
carbohydratebind
lectin
properti
might
role
retrocyclin
activ
influenza
viru
bind
surfact
protein
inhibit
viral
entri
crosslink
immobil
membran
glycoprotein
role
membran
fusion
cell
chicken
embryo
transfect
show
reduc
infect
avian
influenza
viru
clear
whether
cell
express
cyclic
retrocyclin
chemic
synthes
truncat
qdefensin
analogu
also
shown
antiinfluenza
activ
furthermor
seri
qdefensin
analogu
inhibit
entri
herp
simplex
viru
cell
bind
surfac
figur
simplifi
mechan
hiv
viru
entri
host
cell
hiv
viru
attach
host
cell
membran
bind
viral
protein
receptor
host
cell
surfac
chang
conform
allow
bind
coreceptor
either
chemokin
receptor
coreceptor
bind
expos
hydrophob
fusion
peptid
insert
host
cell
membran
subunit
trimer
protein
fold
half
form
sixhelix
bundl
draw
viral
host
cell
membran
togeth
result
membran
fusion
retrocyclin
thought
inhibit
hiv
entri
bind
sixhelix
bundl
glycoprotein
effect
prophylaxi
herp
simplex
viru
type
kerat
mous
model
obviou
applic
qdefensin
use
antimicrobi
although
antibacteri
activ
compar
antimicrobi
peptid
potent
antihiv
activ
qdefensin
garner
interest
sever
report
propos
use
retrocyclin
topic
microbicid
reduc
transmiss
dissolv
polyvinyl
alcohol
film
formul
test
vitro
ex
vivo
safeti
efficaci
vagin
microbicid
longterm
stabil
bioavail
test
still
need
carri
recent
report
suggest
qdefensin
could
also
use
immunomodulatori
agent
aand
bdefensin
stimul
adapt
immun
respons
qdefensin
suppress
product
proinflammatori
cytokin
modul
immun
respons
polymicrobi
sepsi
model
mice
dose
lower
level
tumor
necrosi
factor
interleukin
furthermor
system
administ
qdefensin
nontox
stabl
plasma
stimul
immun
respons
adult
chimpanze
earlier
studi
prophylact
treatment
prevent
lethal
infect
mice
mouseadapt
strain
sever
acut
respiratori
syndrom
coronaviru
howev
qdefensin
neither
virusnor
lipopolysaccharid
lp
neutral
suggest
immunomodulatori
activ
abil
bind
carbohydratecontain
cellsurfac
receptor
help
prevent
viral
infect
furthermor
bind
cellsurfac
receptor
plasma
protein
might
concentr
qdefensin
infect
site
qdefensin
attract
scaffold
peptid
drug
design
constrain
structur
stabil
low
cytotox
inher
bioactiv
concept
prototyp
design
templat
appli
tachyplesin
analogu
similar
rigid
structur
qdefensin
addit
advantag
cyclic
backbon
proofofconcept
qdefensin
use
scaffold
peptid
drug
cyclic
cystin
ladder
use
constrain
stabil
integrinbind
argglyasp
rgd
sequenc
either
one
loop
rgdcontain
qdefensin
show
potent
select
integrinbind
activ
illustr
qdefensin
scaffold
acquir
nonn
bioactiv
furthermor
higher
integrinbind
activ
analogu
contain
rgd
loop
suggest
natur
symmetri
qdefensin
might
exploit
design
bifunct
peptid
therapeut
develop
chemic
synthesi
strategi
qdefensin
analogu
help
drive
applic
drug
scaffold
provid
access
novel
molecul
contain
unnatur
amino
acid
label
mutat
chemic
modif
saw
emerg
new
field
cyclic
peptid
structur
ribosom
origin
cyclic
peptid
bacteria
fungi
plant
elucid
discoveri
qdefensin
reveal
mammal
also
produc
cyclic
peptid
sinc
chemic
tool
discoveri
sequenc
synthesi
structur
determin
facilit
investig
structur
mechan
action
cyclic
peptid
interest
antimicrobi
properti
qdefensin
led
mechanist
insight
discoveri
new
qdefensin
lag
consider
behind
cyclic
peptid
furthermor
biosynthet
mechan
qdefensin
two
separ
gene
product
remain
one
intrigu
yet
elus
question
field
grow
interest
peptidebas
drug
pharmaceut
industri
well
increas
number
valid
target
drug
disrupt
proteinprotein
interact
provid
mani
opportun
applic
qdefensin
studi
structur
mechan
action
synthesi
qdefensin
help
promot
develop
therapeut
agent
anticip
next
year
see
discoveri
new
qdefensin
develop
novel
applic
base
favor
chemic
properti
biolog
activ
work
laboratori
cyclic
peptid
fund
australian
research
council
grant
id
nation
health
medic
research
council
grant
id
djc
nhmrc
professori
fellow
grant
id
acc
support
univers
queensland
intern
phd
scholarship
